IRCT20161023030445N2 IRCT 2018-03-26 Vice Chancellor for research of Kurdistan University of Medical Sciences Effect of Propolis on Non-alcoholic fatty liver disease NAFLD Effect of Propolis on liver functional indexes in patients with Non-alcoholic fatty liver disease 2017-12-22 anticipated 50 Complete https://irct.ir/trial/24184 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: using block randomization method with a block size of 4. The list of randomization was computer-generated and a person, who was not aware of the nature of the trial, packed the supplements and placebo capsules in numbered bottles based on the list. The other person who was not aware of random sequences allocated the patients to the numbered bottles, Blinding description: All supplements and placebo capsules were identical with respect to appearance and only differed in coding of the capsules. The treatment code of the intervention supplements was blinded for subjects, investigators and staff involved in the conduct of the study. 3 Nonalcoholic fatty liver disease (NAFLD). Intervention 1: Control group: placebo containing starch, oral capsule, 500 mg, twice a day for three months with standard treatment. Intervention 2: Intervention group: Propolis, oral capsule, 500 mg, twice a day for three months with standard treatment. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information